Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros










Intervalo de año de publicación
1.
Photobiomodul Photomed Laser Surg ; 42(4): 314-320, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38536111

RESUMEN

Background: Acinetobacter baumannii, a nosocomial pathogen, poses a major public health problem due to generating resistance to several antimicrobial agents. Antimicrobial photodynamic inactivation (APDI) employs a nontoxic dye as a photosensitizer (PS) and light to produce reactive oxygen species that destroy bacterial cells. The intracellular concentration of PS could be affected by factors such as the function of efflux pumps to emit PS from the cytosol. Objective: To evaluate the augmentation effect of an efflux pump inhibitor, verapamil, three multidrug-resistant A. baumannii were subjected to APDI by erythrosine B (EB). Methods and results: The combination of EB and verapamil along with irradiation at 530 nm induced a lethal effect and more than 3 log colony-forming unit reduction to all A. baumannii strains in planktonic state. In contrast, EB and irradiation alone could produce only a sublethal effect on two of the strains. Conclusions: These data suggest that verapamil increases the intracellular concentration of EB, which potentiates the lethal efficacy of APDI. Verapamil could be applied with EB and green light to improve their antimicrobial efficacy against A. baumannii-localized infections.


Asunto(s)
Acinetobacter baumannii , Farmacorresistencia Bacteriana Múltiple , Eritrosina , Colorantes Fluorescentes , Fármacos Fotosensibilizantes , Verapamilo , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/efectos de la radiación , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Fármacos Fotosensibilizantes/farmacología , Verapamilo/farmacología , Eritrosina/metabolismo , Colorantes Fluorescentes/metabolismo , Luz
2.
Theranostics ; 10(26): 12241-12262, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33204340

RESUMEN

The development of nanomedicine is expected to provide an innovative direction for addressing challenges associated with multidrug-resistant (MDR) bacteria. In the past decades, although nanotechnology-based phototherapy has been developed for antimicrobial treatment since it rarely causes bacterial resistance, the clinical application of single-mode phototherapy has been limited due to poor tissue penetration of light sources. Therefore, combinatorial strategies are being developed. In this review, we first summarized the current phototherapy agents, which were classified into two functional categories: organic phototherapy agents (e.g., small molecule photosensitizers, small molecule photosensitizer-loaded nanoparticles and polymer-based photosensitizers) and inorganic phototherapy agents (e.g., carbo-based nanomaterials, metal-based nanomaterials, composite nanomaterials and quantum dots). Then the development of emerging phototherapy-based combinatorial strategies, including combination with chemotherapy, combination with chemodynamic therapy, combination with gas therapy, and multiple combination therapy, are presented and future directions are further discussed. The purpose of this review is to highlight the potential of phototherapy to deal with bacterial infections and to propose that the combination therapy strategy is an effective way to solve the challenges of single-mode phototherapy.


Asunto(s)
Antibacterianos/farmacología , Infecciones Bacterianas/tratamiento farmacológico , Fármacos Fotosensibilizantes/administración & dosificación , Fototerapia/métodos , Nanomedicina Teranóstica/métodos , Animales , Antibacterianos/uso terapéutico , Infecciones Bacterianas/microbiología , Terapia Combinada/métodos , Modelos Animales de Enfermedad , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Humanos , Luz , Nanopartículas/administración & dosificación , Puntos Cuánticos/administración & dosificación
3.
J Nanobiotechnology ; 18(1): 59, 2020 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-32293461

RESUMEN

BACKGROUND: Infectious diseases caused by multidrug-resistant (MDR) bacteria, especially MDR Gram-negative strains, have become a global public health challenge. Multifunctional nanomaterials for controlling MDR bacterial infections via eradication of planktonic bacteria and their biofilms are of great interest. RESULTS: In this study, we developed a multifunctional platform (TG-NO-B) with single NIR laser-triggered PTT and NO release for synergistic therapy against MDR Gram-negative bacteria and their biofilms. When located at the infected sites, TG-NO-B was able to selectively bind to the surfaces of Gram-negative bacterial cells and their biofilm matrix through covalent coupling between the BA groups of TG-NO-B and the bacterial LPS units, which could greatly improve the antibacterial efficiency, and reduce side damages to ambient normal tissues. Upon single NIR laser irradiation, TG-NO-B could generate hyperthermia and simultaneously release NO, which would synergistically disrupt bacterial cell membrane, further cause leakage and damage of intracellular components, and finally induce bacteria death. On one hand, the combination of NO and PTT could largely improve the antibacterial efficiency. On the other hand, the bacterial cell membrane damage could improve the permeability and sensitivity to heat, decrease the photothermal temperature and avoid damages caused by high temperature. Moreover, TG-NO-B could be effectively utilized for synergistic therapy against the in vivo infections of MDR Gram-negative bacteria and their biofilms and accelerate wound healing as well as exhibit excellent biocompatibility both in vitro and in vivo. CONCLUSIONS: Our study demonstrates that TG-NO-B can be considered as a promising alternative for treating infections caused by MDR Gram-negative bacteria and their biofilms.


Asunto(s)
Biopelículas/efectos de la radiación , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Bacterias Gramnegativas/fisiología , Rayos Infrarrojos , Óxidos de Nitrógeno/metabolismo , Animales , Materiales Biocompatibles/química , Materiales Biocompatibles/metabolismo , Materiales Biocompatibles/farmacología , Biopelículas/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/patología , Infecciones por Bacterias Gramnegativas/terapia , Infecciones por Bacterias Gramnegativas/veterinaria , Grafito/química , Hemólisis/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Células 3T3 NIH , Nanoestructuras/química , Nanoestructuras/toxicidad , Fototerapia , Temperatura , Distribución Tisular , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/efectos de la radiación
4.
BMC Infect Dis ; 20(1): 82, 2020 Jan 29.
Artículo en Inglés | MEDLINE | ID: mdl-31996170

RESUMEN

BACKGROUND: No-touch environmental disinfection using ultraviolet devices has been highlighted in the past several years to control the transmission of multidrug-resistant organisms (MDROs). However, its effectiveness in non-US healthcare settings is yet to be examined. This study aimed to evaluate the effectiveness of disinfection by portable pulsed xenon ultraviolet (PX-UV) devices in controlling transmission of MDROs in a non-US healthcare setting. METHODS: All patients admitted in the intensive care unit in a 629-bed tertiary referral hospital in Japan from August 2016 to February 2019 were enrolled. During the study period, PX-UV disinfection was added to manual terminal cleaning after every patient transfer/discharge. For microbiological evaluation, surfaces were selected for sampling by contact plates before/after manual cleaning and after PX-UV. After overnight incubation, colonies on the plates were counted. RESULTS: The incidence of newly acquired methicillin-resistant Staphylococcus aureus (MRSA) declined significantly (13.8 to 9.9 per 10,000 patient days, incidence rate ratio 0.71, p = 0.002), as well as that of newly acquired drug-resistant Acinetobacter (48.5 to 18.1, 0.37, p < 0.001). The percent reduction of the microbiological burden by manual cleaning was 81%, but a further 59% reduction was achieved by PX-UV. CONCLUSIONS: PX-UV is effective in further reducing the microbial burden and controlling MDROs in a non-US healthcare setting.


Asunto(s)
Acinetobacter baumannii/efectos de la radiación , Infección Hospitalaria/prevención & control , Desinfección/métodos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Staphylococcus aureus Resistente a Meticilina/efectos de la radiación , Estudios Controlados Antes y Después , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Desinfección/instrumentación , Humanos , Incidencia , Unidades de Cuidados Intensivos , Japón/epidemiología , Centros de Atención Terciaria , Rayos Ultravioleta , Xenón
5.
J Infect Dis ; 221(4): 618-626, 2020 02 03.
Artículo en Inglés | MEDLINE | ID: mdl-31565732

RESUMEN

BACKGROUND: Antimicrobial resistance is a significant concern to public health, and there is a pressing need to develop novel antimicrobial therapeutic modalities. METHODS: In this study, we investigated the capacity for quinine hydrochloride (Q-HCL) to enhance the antimicrobial effects of antimicrobial blue light ([aBL] 405 nm wavelength) against multidrug-resistant (MDR) Gram-negative bacteria in vitro and in vivo. RESULTS: Our findings demonstrated the significant improvement in the inactivation of MDR Pseudomonas aeruginosa and Acinetobacter baumannii (planktonic cells and biofilms) when aBL was illuminated during Q-HCL exposure. Furthermore, the addition of Q-HCL significantly potentiated the antimicrobial effects of aBL in a mouse skin abrasion infection model. In addition, combined exposure of aBL and Q-HCL did not result in any significant apoptosis when exposed to uninfected mouse skin. CONCLUSIONS: In conclusion, aBL in combination with Q-HCL may offer a novel approach for the treatment of infections caused by MDR bacteria.


Asunto(s)
Infecciones por Acinetobacter/tratamiento farmacológico , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/efectos de la radiación , Antibacterianos/uso terapéutico , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/efectos de la radiación , Quinina/uso terapéutico , Terapia Ultravioleta/métodos , Infecciones por Acinetobacter/microbiología , Acinetobacter baumannii/fisiología , Animales , Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Biopelículas/efectos de la radiación , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Femenino , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Plancton/microbiología , Pseudomonas aeruginosa/fisiología , Quinina/farmacología , Piel/lesiones , Piel/microbiología , Piel/patología , Resultado del Tratamiento , Heridas y Lesiones/microbiología
6.
mSphere ; 4(3)2019 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-31043515

RESUMEN

Silver nanoparticles (AgNPs) are known for their broad-spectrum antibacterial properties, especially against antibiotic-resistant bacteria. However, the bactericidal mechanism of AgNPs remains unclear. In this study, we found that the bactericidal ability of AgNPs is induced by light. In contrast to previous postulates, visible light is unable to trigger silver ion release from AgNPs or to promote AgNPs to induce reactive oxygen species (ROS) in Escherichia coli In fact, we revealed that light excited AgNPs to induce protein aggregation in a concentration-dependent manner in E. coli, indicating that the bactericidal ability of AgNPs relies on the light-catalyzed oxidation of cellular proteins via direct binding to proteins, which was verified by fluorescence spectra. AgNPs likely absorb the light energy and transfer it to the proteins, leading to the oxidation of proteins and thus promoting the death of the bacteria. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics revealed that the bacteria failed to develop effective resistance to the light-excited AgNPs. This direct physical mechanism is unlikely to be counteracted by any known drug resistance mechanisms of bacteria and therefore may serve as a last resort against drug resistance. This mechanism also provides a practical hint regarding the antimicrobial application of AgNPs-light exposure improves the efficacy of AgNPs.IMPORTANCE Although silver nanoparticles (AgNPs) are well known for their antibacterial properties, the mechanism by which they kill bacterial cells remains a topic of debate. In this study, we uncovered the bactericidal mechanism of AgNPs, which is induced by light. We tested the efficacy of AgNPs against a panel of antimicrobial-resistant pathogens as well as Escherichia coli under conditions of light and darkness and revealed that light excited the AgNPs to promote protein aggregation within the bacterial cells. Our report makes a significant contribution to the literature because this mechanism bypasses microbial drug resistance mechanisms, thus presenting a viable option for the treatment of multidrug-resistant bacteria.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Escherichia coli/efectos de la radiación , Luz , Plata/farmacología , Catálisis , Escherichia coli/efectos de los fármacos , Nanopartículas del Metal/química , Pruebas de Sensibilidad Microbiana , Estrés Oxidativo , Agregado de Proteínas , Plata/química
7.
FEMS Microbiol Lett ; 366(3)2019 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-30715289

RESUMEN

Low-intensity and low-frequency ultrasound (LILFU) can enhance the bactericidal action of antibiotics against various sensitive bacterial species. The current study investigated the effects of LILFU combined with tobramycin on extended-spectrum beta-lactamases (ESBLs) Escherichia coli biofilms (a multi-drug resistant bacteria). The biofilms of ESBLs E. coli were established and treated with ultrasound (42 kHz and ISATA of 0.66 W/cm2) continuously for 0.5 h with and without tobramycin. The bacterial viability, the morphology and the antibiotic penetration of ESBLs E. Coli biofilms were investigated. The results demonstrated that the bacterial viability of biofilms significantly declined and the diameter of the inhibition zone was significantly increased after treatment with ultrasound combined with tobramycin compared with the controls (P < 0.05). Confocal laser scanning microscopy showed that the bacterial viability was affected most in the outer layer of ESBLs E. coli biofilms after joint treatment. The morphological structure of the biofilms was altered remarkably after joint treatment based on scanning electron microscopy, especially in regard to reduced thickness and loosened structure. These results suggest that the combination of ultrasound and tobramycin can exert synergistic bactericidal effects against biofilms formed by ESBLs E. coli.


Asunto(s)
Biopelículas , Farmacorresistencia Bacteriana Múltiple , Escherichia coli/efectos de los fármacos , Escherichia coli/efectos de la radiación , Viabilidad Microbiana , Tobramicina/farmacología , Ondas Ultrasónicas , Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Biopelículas/efectos de la radiación , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Escherichia coli/enzimología , Escherichia coli/ultraestructura , Viabilidad Microbiana/efectos de los fármacos , Viabilidad Microbiana/efectos de la radiación , Microscopía Confocal , Microscopía Electrónica de Rastreo , beta-Lactamasas/metabolismo
8.
J Infect Dis ; 220(5): 873-881, 2019 07 31.
Artículo en Inglés | MEDLINE | ID: mdl-30629196

RESUMEN

Antimicrobial resistance in Neisseria gonorrhoeae is a major issue of public health, and there is a critical need for the development of new antigonococcal strategies. In this study, we investigated the effectiveness of antimicrobial blue light (aBL; wavelength, 405 nm), an innovative nonpharmacological approach, for the inactivation of N. gonorrhoeae. Our findings indicated that aBL preferentially inactivated N. gonorrhoeae, including antibiotic-resistant strains, over human vaginal epithelial cells in vitro. Furthermore, no aBL-induced genotoxicity to the vaginal epithelial cells was observed at the radiant exposure used to inactivate N. gonorrhoeae. aBL also effectively inactivated N. gonorrhoeae that had attached to and invaded into the vaginal epithelial cells in their cocultures. No gonococcal resistance to aBL developed after 15 successive cycles of inactivation induced by subtherapeutic exposure to aBL. Endogenous aBL-activatable photosensitizing porphyrins in N. gonorrhoeae were identified and quantified using ultraperformance liquid chromatography, with coproporphyrin being the most abundant species in all N. gonorrhoeae strains studied. Singlet oxygen was involved in aBL inactivation of N. gonorrhoeae. Together, these findings show that aBL represents a potential potent treatment for antibiotic-resistant gonococcal infection.


Asunto(s)
Gonorrea/radioterapia , Neisseria gonorrhoeae/efectos de la radiación , Abetalipoproteinemia , Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Células Epiteliales/microbiología , Femenino , Gonorrea/tratamiento farmacológico , Humanos , Luz , Pruebas de Sensibilidad Microbiana , Neisseria gonorrhoeae/efectos de los fármacos , Neisseria gonorrhoeae/crecimiento & desarrollo , Oxígeno , Azida Sódica , Vagina/microbiología
10.
Drug Resist Updat ; 31: 31-42, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-28867242

RESUMEN

Infections have been a major cause of disease throughout the history of humans on earth. With the introduction of antibiotics, it was thought that infections had been conquered. However, bacteria have been able to develop resistance to antibiotics at an exponentially increasing rate. The growing threat from multi-drug resistant organisms calls for intensive action to prevent the emergence of totally resistant and untreatable infections. Novel, non-invasive, non-antibiotic strategies are needed that act more efficiently and faster than current antibiotics. One promising alternative is antimicrobial photodynamic inactivation (APDI), an approach that produces reactive oxygen species when dyes and light are combined. So far, it has been questionable if bacteria can develop resistance against APDI. This review paper gives an overview of recent studies concerning the susceptibility of bacteria towards oxidative stress, and suggests possible mechanisms of the development of APDI-resistance that should at least be addressed. Some ways to potentiate APDI and also to overcome future resistance are suggested.


Asunto(s)
Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fotoquimioterapia , Fármacos Fotosensibilizantes/uso terapéutico , Antibacterianos/administración & dosificación , Biopelículas/efectos de los fármacos , Biopelículas/efectos de la radiación , Farmacorresistencia Bacteriana Múltiple/genética , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Bacterias Gramnegativas/metabolismo , Bacterias Gramnegativas/efectos de la radiación , Bacterias Grampositivas/metabolismo , Bacterias Grampositivas/efectos de la radiación , Humanos , Estrés Oxidativo/genética , Estrés Oxidativo/efectos de la radiación , Fármacos Fotosensibilizantes/administración & dosificación
11.
Photodiagnosis Photodyn Ther ; 18: 1-5, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28088439

RESUMEN

Nosocomially-acquired multi-, extensively-, and pandrug resistant (MDR, XDR, and PDR) strains of microorganisms such as Acinetobacter baumannii remain a serious cause of infection and septic mortality in burn patients. Treatment of patients with nosocomial burn wound infections is often complicated by drug-resistant strains of A. baumannii. Today, many researchers are focusing on the investigation of novel non-antibiotic strategies such as photodynamic therapy (PDT). We report a new PDT strategy that suppresses colistin resistance in PDR A. baumannii by interfering with the expression of a pmrA/pmrB two-component system. In the current study, A. baumannii with a PDR feature isolated from a burn patient was used as a test strain. PDT was carried out using toluidine blue O (TBO) and light-emitting diode (LED) as a photosensitizer and radiation source, respectively. The antimicrobial susceptibility profiles were assessed for cells surviving PDT. The effects of sub-lethal PDT (sPDT) on the expression of the pmrA/pmrB two-component signal transduction system were evaluated by real-time quantitative reverse transcription PCR. Results of drug susceptibly testing (DST) in LED and TBO groups separately showed that the bacteria were resistant to all tested antibiotics, while the DST result of the LED+TBO group showed highly declining bacterial growth when compared with the control group. Reduction in the expression of pmrA and pmrB was observed in the treated strains after sPDT. This represents the first conclusive example of a direct role for the PDT in breaking antibiotic resistance by directly modulating two-component system activity.


Asunto(s)
Infecciones por Acinetobacter/tratamiento farmacológico , Acinetobacter baumannii/efectos de los fármacos , Colistina/administración & dosificación , Colistina/farmacología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Fotoquimioterapia , Infecciones por Acinetobacter/microbiología , Infecciones por Acinetobacter/patología , Acinetobacter baumannii/efectos de la radiación , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Quemaduras/tratamiento farmacológico , Quemaduras/microbiología , Terapia Combinada , Descontaminación , Relación Dosis-Respuesta a Droga , Relación Dosis-Respuesta en la Radiación , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Humanos , Fármacos Fotosensibilizantes/administración & dosificación , Fármacos Fotosensibilizantes/farmacología , Cloruro de Tolonio/administración & dosificación , Cloruro de Tolonio/farmacología , Resultado del Tratamiento
12.
J Photochem Photobiol B ; 148: 43-50, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25874661

RESUMEN

Solar disinfection and solar-driven advanced oxidation processes (AOPs) (namely H2O2/sunlight, TiO2/sunlight, H2O2/TiO2/sunlight, solar photo-Fenton) were evaluated in the inactivation of indigenous antibiotic-resistant bacteria (ARB) in real urban wastewater. A multidrug resistant (MDR) Escherichia coli strain isolated from the effluent of the biological process of an urban wastewater treatment plant was the target ARB. The higher inactivation rates (residual density under detection limit, 2 CFUm L(-1)) were achieved with H2O2/TiO2/sunlight (cumulative energy per unit of volume (QUV) in the range 3-5 kJ L(-1), depending on H2O2/TiO2 ratio) and H2O2/sunlight (QUV of 8 kJ L(-1)) processes. All investigated processes did not affect antibiotic resistance of survived colonies. Moreover, H2O2/sunlight was compared with conventional chlorination process to evaluate bacterial regrowth potential and particularly the proportion of indigenous MDR E. coli with respect to total indigenous E. coli population. Chlorination (1.0 mg Cl2 L(-1)) was more effective than H2O2/sunlight (50 mg H2O2 L(-1)) to achieve total inactivation of MDR E. coli (15 min Vs 90 min) but less effective in controlling their regrowth (24 h Vs 48 h). Interestingly, the percentage of MDR E. coli in H2O2/sunlight treated samples decreased as incubation time increased; the opposite was observed for chlorinated samples.


Asunto(s)
Desinfección/métodos , Peróxido de Hidrógeno/química , Hierro/química , Luz Solar , Aguas Residuales/microbiología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Escherichia coli/efectos de los fármacos , Escherichia coli/efectos de la radiación , Halogenación , Titanio/química , Eliminación de Residuos Líquidos
13.
PLoS One ; 9(12): e111792, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25469700

RESUMEN

Photodynamic inactivation of bacteria (PIB) proves to be an additional method to kill pathogenic bacteria. PIB requires photosensitizer molecules that effectively generate reactive oxygen species like singlet oxygen when exposed to visible light. To allow a broad application in medicine, photosensitizers should be safe when applied in humans. Substances like vitamin B2, which are most likely safe, are known to produce singlet oxygen upon irradiation. In the present study, we added positive charges to flavin derivatives to enable attachment of these molecules to the negatively charged surface of bacteria. Two of the synthesized flavin derivatives showed a high quantum yield of singlet oxygen of approximately 75%. Multidrug resistant bacteria like MRSA (Methicillin resistant Staphylococcus aureus), EHEC (enterohemorrhagic Escherichia coli), Pseudomonas aeruginosa, and Acinetobacter baumannii were incubated with these flavin derivatives in vitro and were subsequently irradiated with visible light for seconds only. Singlet oxygen production in bacteria was proved by detecting its luminescence at 1270 nm. After irradiation, the number of viable bacteria decreased up to 6 log10 steps depending on the concentration of the flavin derivatives and the light dosimetry. The bactericidal effect of PIB was independent of the bacterial type and the corresponding antibiotic resistance pattern. In contrast, the photosensitizer concentration and light parameters used for bacteria killing did not affect cell viability of human keratinocytes (therapeutic window). Multiresistant bacteria can be safely and effectively killed by a combination of modified vitamin B2 molecules, oxygen and visible light, whereas normal skin cells survive. Further work will include these new photosensitizers for topical application to decolonize bacteria from skin and mucosa.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Fármacos Fotosensibilizantes/farmacología , Riboflavina/análogos & derivados , Oxígeno Singlete/farmacología , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/efectos de la radiación , Infecciones Bacterianas/terapia , Línea Celular , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Escherichia coli Enterohemorrágica/efectos de los fármacos , Escherichia coli Enterohemorrágica/efectos de la radiación , Humanos , Queratinocitos/microbiología , Luz , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/efectos de la radiación , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/efectos de la radiación , Riboflavina/síntesis química , Riboflavina/farmacología
14.
Chem Commun (Camb) ; 50(72): 10488-90, 2014 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-25068798

RESUMEN

To integrate photodynamic therapy with photothermal therapy for improved multidrug-resistant bacteria therapy, we have constructed a novel multifunctional core/satellite nanostructure by decorating CuS nanoparticles onto the surface of NaYF4:Mn/Yb/Er@photosensitizer doped SiO2. This system exhibited a superior antibacterial activity towards drug-resistant Staphylococcus aureus and Escherichia coli.


Asunto(s)
Antibacterianos/química , Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Rayos Infrarrojos , Nanopartículas/química , Cobre/química , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Escherichia coli/efectos de los fármacos , Escherichia coli/efectos de la radiación , Fluoruros/química , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/efectos de la radiación , Azul de Metileno/química , Fármacos Fotosensibilizantes/química , Dióxido de Silicio/química , Itrio/química
15.
Photodiagnosis Photodyn Ther ; 10(4): 694-702, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24284129

RESUMEN

We investigated the effects of photodynamic therapy (PDT) on anti-tuberculosis (TB) activity by measuring inactivation rates, expressed as D-value, of MDR- and XDR-Mycobacterium tuberculosis (M. tb) clinical strains in vitro. Approximately 10(6) colony forming unit per milliliter (CFU/ml) of the bacilli were irradiated with various doses of laser light after exposure to photosensitizers. Survival of M. tb was measured by enumerating CFU in 7H10 medium to measure D-values. No inactivation of M. tb was observed when exposed to photosensitizers (radachlorin or DH-I-180-3) only or laser light only (P>0.1). Treatment with a combination of photosentizer and laser inactivated M. tb although there was a significant difference between the types of photosensitizers applied (P<0.05). Linear inactivation curves for the clinical M. tb strains were obtained up to laser doses of 30 J/cm(2) but prolonged irradiation did not linearly inactivate M. tb, yielding sigmoid PDT inactivation curves. D-values of M. tb determined from the slope of linear regression lines in PDT were not significantly different and ranged from 10.50 to 12.13 J/cm(2) with 670 nm laser irradiation at 100 mW/cm(2) of the fluency rate, except for a drug-susceptible strain among the clinical strains tested. This suggests that PDT inactivated M. tb clinical strains regardless of drug resistance levels of the bacilli. Intermittent and repeated PDT allowed acceleration of the inactivation of the bacilli as a way to avoid the sigmoid inactivation curves. In conclusion, PDT could be alternative as a new option for treatment for MDR- and XDR-tuberculosis.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Mycobacterium tuberculosis/efectos de los fármacos , Fotoquimioterapia/métodos , Porfirinas/administración & dosificación , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , Clorofila/análogos & derivados , Relación Dosis-Respuesta a Droga , Relación Dosis-Respuesta en la Radiación , Farmacorresistencia Bacteriana Múltiple/fisiología , Mycobacterium tuberculosis/fisiología , Mycobacterium tuberculosis/efectos de la radiación , Fármacos Fotosensibilizantes/administración & dosificación , Resultado del Tratamiento
16.
Chemistry ; 19(8): 2839-47, 2013 Feb 18.
Artículo en Inglés | MEDLINE | ID: mdl-23296491

RESUMEN

Over the last few years, one of the most important and complex problems facing our society is treating infectious diseases caused by multidrug-resistant bacteria (MDRB), by using current market-existing antibiotics. Driven by this need, we report for the first time the development of the multifunctional popcorn-shaped iron magnetic core-gold plasmonic shell nanotechnology-driven approach for targeted magnetic separation and enrichment, label-free surface-enhanced Raman spectroscopy (SERS) detection, and the selective photothermal destruction of MDR Salmonella DT104. Due to the presence of the "lightning-rod effect", the core-shell popcorn-shaped gold-nanoparticle tips provided a huge field of SERS enhancement. The experimental data show that the M3038 antibody-conjugated nanoparticles can be used for targeted separation and SERS imaging of MDR Salmonella DT104. A targeted photothermal-lysis experiment, by using 670 nm light at 1.5 W cm(-2) for 10 min, results in selective and irreparable cellular-damage to MDR Salmonella. We discuss the possible mechanism and operating principle for the targeted separation, label-free SERS imaging, and photothermal destruction of MDRB by using the popcorn-shaped magnetic/plasmonic nanotechnology.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Oro/química , Hierro/química , Nanopartículas del Metal/química , Nanotecnología/métodos , Salmonella/química , Salmonella/efectos de los fármacos , Resonancia por Plasmón de Superficie/métodos , Calor , Interacciones Hidrofóbicas e Hidrofílicas , Luz , Magnetismo , Espectrometría Raman
17.
Lasers Med Sci ; 25(5): 743-8, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20552385

RESUMEN

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital acquired infection throughout the world especially in wound and burn infections, pneumonia, septicaemia and endocarditis. We describe the effect of a HeNe laser in combination with a TBO dye on the viability of MRSA. A total of 34 isolates of S. aureus were obtained from 100 patients suffering from burns or wounds and from the nasal vestibulum of medical and nonmedical staff as carriers; eight isolates were methicillin-resistant. The isolates were exposed for 5, 10 and 15 min to a HeNe laser at a wavelength of 632.8 nm and 7.5 mW output power in the presence of 50 microg/ml toluidune blue O photosensitizer. The viable count was substantially decreased as determined by the plate count method for the three exposure times, with 100% killing with the 15-min exposure time. No significant effect was observed on MRSA isolates exposed to the laser alone. So MRSA was completely eradicated following 15 min exposure to a 632.8-nm HeNe laser in the presence of 50 microg/ml toluidune blue O photosensitizer under in vitro conditions.


Asunto(s)
Láseres de Gas , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/efectos de la radiación , Fármacos Fotosensibilizantes/farmacología , Carga Bacteriana/efectos de los fármacos , Carga Bacteriana/efectos de la radiación , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/microbiología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Humanos , Técnicas In Vitro , Láseres de Gas/uso terapéutico , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Fotoquimioterapia , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/microbiología , Cloruro de Tolonio/farmacología
18.
Lasers Surg Med ; 41(5): 391-7, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19533759

RESUMEN

BACKGROUND AND OBJECTIVES: Multidrug-resistant (MDR) Pseudomonas aeruginosa infection is becoming a critical problem worldwide. Currently, only limited therapeutic options are available for the treatment of infections caused by MDR P. aeruginosa, therefore, the development of new alternative treatments is needed. Toluidine blue O (TBO) is an effective antibacterial photosensitizing agent against various bacteria. However, reports on antibacterial photosensitization of MDR bacteria are limited. This study aims to determine the in vitro photobactericidal activity of TBO against MDR P. aeruginosa. STUDY DESIGN/MATERIALS AND METHODS: The efficacy of antibacterial photodynamic inactivation, DNA fragmentation and protein carbonylation of three MDR P. aeruginosa strains and one susceptible strain was compared using TBO as the photosensitizer followed by red light irradiation (630 nm, 90 J/cm(2)) from a light-emitting diode light source. Subsequently, the efficacy of TBO photodynamic inactivation (TBO-PDI) on 60 MDR strains, including 11 with the efflux pump phenotype and 49 with no pump activity, was tested using the minimum lethal drug concentration (MLC) assay. RESULTS: TBO-PDI caused similar bactericidal effect (6-7 logs of killing effect), DNA fragmentation and protein carbonylation in three MDR and one susceptible P. aeruginosa strains. Although the TBO accumulation assay indicated that TBO is a substrate for the efflux pump, TBO-PDI produce similar photobactericidal activity against 60 MDR P. aeruginosa strains, either with or without efflux-pump phenotype, and 19 susceptible strains. CONCLUSION: MDR did not affect the susceptibility of P. aeruginosa strains to TBO-PDI. The efflux pump played an insignificant role in TBO-PDI of MDR P. aeruginosa.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de la radiación , Fotoquimioterapia , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/efectos de la radiación , Cloruro de Tolonio/farmacología , Humanos , Pruebas de Sensibilidad Microbiana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...